DelveInsight is a prominent provider of valuable research within biotech and pharmaceutical industries. It offers analytical reports in such Health Care sectors as gene therapy, medical oncologic therapy, Active Pharmaceutical Ingredient (API) manufacturing, stem cell medication, biosimilars, orphan drugs and others. The expertise includes:
- Company’s profile and licensing data;
- New technology studies;
- Biologic benchmarking;
- Treatment modality analysis;
- Competitive landscape;
- Product assessment; etc.
This knowledge is essential for Generic and Drug Development companies, which also receive drug sales estimation and product performance forecasts.
DelveInsight reconciles customers need for information and for innovative approaches in business development. Consequently, the obtained data is turned into strategic design, partner up opportunities, profit earning capacity of the business. DelveInsight analysts assist pharma enterprises in launching new products and marketing development of existing pharmaceutics.
Publications found:
6,889
Sort by:
Chronic Liver Disease - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Chronic Liver Disease Key assessments Patient Segmentation in Chronic Liver Disease Chronic Liver Disease Risk & Burden Factors driving growth in a specific Chronic Liver Disease patient population
January 2022
60 pages
Chronic Plaque Psoriasis - Epidemiology Forecast to 2032
US$ 3,950.00
... with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Chronic Plaque Psoriasis Key assessments Patient Segmentation in Chronic Plaque Psoriasis Chronic Plaque Psoriasis Risk & Burden Factors driving growth in a specific Chronic Plaque Psoriasis patient population
January 2022
60 pages
Condyloma - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Condyloma Key assessments Patient Segmentation in Condyloma Condyloma Risk & Burden Factors driving growth in a specific Condyloma patient population
January 2022
60 pages
Corlanor - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Corlanor API intelligence over Corlanor and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Crestor - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Crestor API intelligence over Crestor and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Cubicin - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Cubicin API intelligence over Cubicin and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Cushing's Syndrome - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Cushing's Syndrome Key assessments Patient Segmentation in Cushing's Syndrome Cushing's Syndrome Risk & Burden Factors driving growth in a specific Cushing's Syndrome patient population
January 2022
60 pages
Cutaneous Squamous cell Carcinoma (CsCC) - Epidemiology Forecast to 2032
US$ 3,950.00
... Forecast 7MM Coverage Total Cases in Cutaneous Squamous cell Carcinoma (CsCC) Key assessments Patient Segmentation in Cutaneous Squamous cell Carcinoma (CsCC) Cutaneous Squamous cell Carcinoma (CsCC) Risk & Burden Factors driving growth in a specific Cutaneous Squamous cell Carcinoma (CsCC) patient population ...
January 2022
60 pages
Cutaneous T-Cell Lymphoma(CTCL) - Epidemiology Forecast to 2032
US$ 3,950.00
... the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Cutaneous T-Cell Lymphoma(CTCL) Key assessments Patient Segmentation in Cutaneous T-Cell Lymphoma(CTCL) Cutaneous T-Cell Lymphoma(CTCL) Risk & Burden Factors driving growth in a specific Cutaneous T-Cell Lymphoma(CTCL) patient ...
January 2022
60 pages
Cystitis - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Cystitis Key assessments Patient Segmentation in Cystitis Cystitis Risk & Burden Factors driving growth in a specific Cystitis patient population
January 2022
60 pages
Daklinza - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Daklinza API intelligence over Daklinza and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Diabetic Retinopathy - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Diabetic retinopathy Key assessments Patient Segmentation in Diabetic retinopathy Diabetic retinopathy Risk & Burden Factors driving growth in a specific Diabetic retinopathy patient population
January 2022
60 pages
Duavee - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Duavee API intelligence over Duavee and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Dyskinesia - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Dyskinesia Key assessments Patient Segmentation in Dyskinesia Dyskinesia Risk & Burden Factors driving growth in a specific Dyskinesia patient population
January 2022
60 pages
Dyspepsia - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Dyspepsia Key assessments Patient Segmentation in Dyspepsia Dyspepsia Risk & Burden Factors driving growth in a specific Dyspepsia patient population
January 2022
60 pages
Dysport - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Dysport API intelligence over Dysport and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Endometriosis - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Endometriosis Key assessments Patient Segmentation in Endometriosis Endometriosis Risk & Burden Factors driving growth in a specific Endometriosis patient population
January 2022
60 pages
Entresto - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Entresto API intelligence over Entresto and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Epithelial Ovarian Cancer - Epidemiology Forecast to 2032
US$ 3,950.00
... respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Epithelial Ovarian Cancer Key assessments Patient Segmentation in Epithelial Ovarian Cancer Epithelial Ovarian Cancer Risk & Burden Factors driving growth in a specific Epithelial Ovarian Cancer patient population
January 2022
60 pages
Epzicom - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Epzicom API intelligence over Epzicom and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Esbriet - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Esbriet API intelligence over Esbriet and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Fallopian Tube Cancer - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Fallopian Tube Cancer Key assessments Patient Segmentation in Fallopian Tube Cancer Fallopian Tube Cancer Risk & Burden Factors driving growth in a specific Fallopian Tube Cancer patient population
January 2022
60 pages
Familial Amyloid Polyneuropathy - Epidemiology Forecast to 2032
US$ 3,950.00
... (Transthyretin Amyloidosis, Corino de Andrade's Disease) Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Risk & Burden Factors driving growth in a specific Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) patient population
January 2022
60 pages
Familial Hypercholesterolemia - Epidemiology Forecast to 2032
US$ 3,950.00
... to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Familial Hypercholesterolemia (Type II Hyperlipoproteinemia Key assessments Patient Segmentation in Familial Hypercholesterolemia (Type II Hyperlipoproteinemia Familial Hypercholesterolemia (Type II Hyperlipoproteinemia Risk ...
January 2022
60 pages
Febrile Neutropenia - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Febrile Neutropenia Key assessments Patient Segmentation in Febrile Neutropenia Febrile Neutropenia Risk & Burden Factors driving growth in a specific Febrile Neutropenia patient population
January 2022
60 pages
Forteo - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Forteo API intelligence over Forteo and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Gastric Ulcers - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Gastric Ulcers Key assessments Patient Segmentation in Gastric Ulcers Gastric Ulcers Risk & Burden Factors driving growth in a specific Gastric Ulcers patient population
January 2022
60 pages
Gastritis - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Gastritis Key assessments Patient Segmentation in Gastritis Gastritis Risk & Burden Factors driving growth in a specific Gastritis patient population
January 2022
60 pages
Gastrointestinal Stromal Tumor (GIST) - Epidemiology Forecast to 2032
US$ 3,950.00
... 10 Year Forecast 7MM Coverage Total Cases in Gastrointestinal Stromal Tumor (GIST) Key assessments Patient Segmentation in Gastrointestinal Stromal Tumor (GIST) Gastrointestinal Stromal Tumor (GIST) Risk & Burden Factors driving growth in a specific Gastrointestinal Stromal Tumor (GIST) patient population
January 2022
60 pages
Gastroparesis - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Gastroparesis Key assessments Patient Segmentation in Gastroparesis Gastroparesis Risk & Burden Factors driving growth in a specific Gastroparesis patient population
January 2022
60 pages
Genvoya - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Genvoya API intelligence over Genvoya and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Gilvec - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Gilvec API intelligence over Gilvec and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Gouty Arthritis (Gout) - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Gouty Arthritis (Gout) Key assessments Patient Segmentation in Gouty Arthritis (Gout) Gouty Arthritis (Gout) Risk & Burden Factors driving growth in a specific Gouty Arthritis (Gout) patient population
January 2022
60 pages
Graft Versus Host Disease (GvHD) - Epidemiology Forecast to 2032
US$ 3,950.00
... patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Graft versus host disease (GVHD) Key assessments Patient Segmentation in Graft versus host disease (GVHD) Graft versus host disease (GVHD) Risk & Burden Factors driving growth in a specific Graft versus host disease (GVHD) patient ...
January 2022
60 pages
Hairy Cell Leukemia - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Hairy Cell Leukemia Key assessments Patient Segmentation in Hairy Cell Leukemia Hairy Cell Leukemia Risk & Burden Factors driving growth in a specific Hairy Cell Leukemia patient population
January 2022
60 pages
Harvoni - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Harvoni API intelligence over Harvoni and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Humalog - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Humalog API intelligence over Humalog and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Human Papillomavirus (HPV) - Epidemiology Forecast to 2032
US$ 3,950.00
... to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Human Papillomavirus (HPV) Key assessments Patient Segmentation in Human Papillomavirus (HPV) Human Papillomavirus (HPV) Risk & Burden Factors driving growth in a specific Human Papillomavirus (HPV) patient population
January 2022
60 pages
Humatrope - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Humatrope API intelligence over Humatrope and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Imbruvica - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Imbruvica API intelligence over Imbruvica and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Interstitial Cystitis - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Interstitial Cystitis Key assessments Patient Segmentation in Interstitial Cystitis Interstitial Cystitis Risk & Burden Factors driving growth in a specific Interstitial Cystitis patient population
January 2022
60 pages
Invokana - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Invokana API intelligence over Invokana and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Jardiance - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Jardiance API intelligence over Jardiance and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Jublia - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Jublia API intelligence over Jublia and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Kengreal - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Kengreal API intelligence over Kengreal and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Lonsurf - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Lonsurf API intelligence over Lonsurf and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Lynparza - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Lynparza API intelligence over Lynparza and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages
Mekinist - API Insight, 2022
US$ 500.00
... patent expiry details with respect to Mekinist API intelligence over Mekinist and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful ...
January 2022
30 pages